Literature DB >> 19546167

Molecular characterization of novel germline deletions affecting SDHD and SDHC in pheochromocytoma and paraganglioma patients.

Jean-Pierre Bayley1, Marjan M Weiss, Anneliese Grimbergen, Bernadette T J van Brussel, Frederik J Hes, Jeroen C Jansen, Senno Verhoef, Peter Devilee, Eleonora P Corssmit, Annette H J T Vriends.   

Abstract

A major cause of paraganglioma and pheochromocytoma is germline mutation of the tumor suppressor genes SDHB, SDHC, and SDHD, encoding subunits of succinate dehydrogenase (SDH). While many SDH missense/nonsense mutations have been identified, few large deletions have been described. We performed multiplex ligation-dependent probe amplification deletion analysis in 126 point mutation-negative patients, and here we describe four novel deletions of SDHD and SDHC. Long-range PCR was used for the fine mapping of deletions. One patient had a 10 kb AluSg-AluSx-mediated deletion including SDHD exons 1 and 2, the entire TIMM8B gene, and deletion of exons of C11orf57. A second patient had a deletion of SDHD exons 1 and 2 and exon 1 of the TIMM8B gene. A third patient showed a deletion of exon 2 of SDHD, together with a 235 bp MIRb-Tensin gene insertion. In a fourth patient, a deletion of exons 5 and 6 of the SDHC gene was found, only the second SDHC deletion currently known. The deletions of the TIMM8B and C11orf57 genes are the first to be described, but do not appear to result in an additional phenotype in these patients. Four of the eight breakpoints occurred in Alu sequences and all three SDHD deletions showed an intron 2 breakpoint. This study underlines the fact that clinically relevant deletions may encompass neighboring genes, with the potential to modify phenotype. Gene deletions of SDHD and SDHC represent a substantial proportion of all mutations, and must be considered in paraganglioma patients shown to be negative for mutations by sequencing.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19546167     DOI: 10.1677/ERC-09-0084

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  5 in total

Review 1.  Recent advances in the genetics of SDH-related paraganglioma and pheochromocytoma.

Authors:  Erik F Hensen; Jean-Pierre Bayley
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

2.  Survival of gastrointestinal stromal tumor patients in the imatinib era: life raft group observational registry.

Authors:  Jerry Call; Christopher D Walentas; Jens C Eickhoff; Norman Scherzer
Journal:  BMC Cancer       Date:  2012-03-19       Impact factor: 4.430

3.  Genetic screening for monogenic hypertension in hypertensive individuals in a clinical setting.

Authors:  Minghui Bao; Ping Li; Qifu Li; Hui Chen; Ying Zhong; Shuangyue Li; Ling Jin; Wenjie Wang; Zhenzhen Chen; Jiuchang Zhong; Bin Geng; Yuxin Fan; Xinchun Yang; Jun Cai
Journal:  J Med Genet       Date:  2020-06-19       Impact factor: 6.318

4.  Genome-wide analysis of human hotspot intersected genes highlights the roles of meiotic recombination in evolution and disease.

Authors:  Tao Zhou; Zhibin Hu; Zuomin Zhou; Xuejiang Guo; Jiahao Sha
Journal:  BMC Genomics       Date:  2013-01-31       Impact factor: 3.969

5.  Pheochromocytoma in a Twelve-Year-Old Girl with SDHB-Related Hereditary Paraganglioma-Pheochromocytoma Syndrome.

Authors:  Daryl Graham; Megan Gooch; Zhan Ye; Edward Richer; Aftab Chishti; Elizabeth Reilly; John D'Orazio
Journal:  Case Rep Genet       Date:  2014-08-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.